Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
ISIG
|
Funicular Fund, LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 1,950 Added 0.14% |
$1,443
$0.74 p/Share
|
Feb 28
2020 |
SIVB
|
Christopher Edmonds Waters
Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct | 1,174 Reduced 24.87% |
$238,462
$203.12 p/Share
|
Feb 28
2020 |
BSQR
|
Ryan L. Vardeman |
BUY
Open market or private purchase
|
Indirect | 23,687 Added 0.0% |
$28,898
$1.22 p/Share
|
Feb 28
2020 |
HBNC
|
Peter L Pairitz
Director |
BUY
Open market or private purchase
|
Direct | 10,000 Added 4.38% |
$148,500
$14.85 p/Share
|
Feb 28
2020 |
SEIC
|
Kevin Barr
Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct | 40,000 Added 17.8% |
$954,400
$23.86 p/Share
|
Feb 28
2020 |
DTIL
|
Dario Scimeca
General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct | 2,072 Added 50.0% |
$11,624
$5.61 p/Share
|
Feb 28
2020 |
OPXS
|
Karen Lea Hawkins
CFO |
BUY
Open market or private purchase
|
Direct | 1,900 Added 0.84% |
$3,800
$2.0 p/Share
|
Feb 28
2020 |
NVCR
|
Wilhelmus Cm Groenhuysen
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 3,670 Reduced 2.39% |
$265,047
$72.22 p/Share
|
Feb 28
2020 |
EGRX
|
Steven B Ratoff
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,340 Added 10.32% |
$20,545
$8.78 p/Share
|
Feb 28
2020 |
TXMD
|
Robert G Finizio
CEO |
SELL
Bona fide gift
|
Direct | 300,000 Reduced 1.65% |
-
|
Feb 28
2020 |
DD
|
Lori Koch
CEO |
BUY
Small Acquisition
|
Indirect | 8 Added 3.9% |
$343
$42.9 p/Share
|
Feb 28
2020 |
ETR
|
Paul D Hinnenkamp
EVP & Chief Operating Officer |
SELL
Bona fide gift
|
Direct | 1,900 Reduced 7.15% |
-
|
Feb 28
2020 |
ETR
|
Phillip R May Jr |
SELL
Bona fide gift
|
Direct | 1,500 Reduced 10.52% |
-
|
Feb 28
2020 |
FCNCA
|
Peter M Bristow
President |
BUY
Bona fide gift
|
Indirect | 66 Added 0.52% |
-
|
Feb 28
2020 |
FCNCA
|
Peter M Bristow
President |
SELL
Bona fide gift
|
Indirect | 198 Reduced 0.56% |
-
|
Feb 28
2020 |
FCNCA
|
Claire H Bristow |
BUY
Bona fide gift
|
Indirect | 66 Added 0.52% |
-
|
Feb 28
2020 |
FCNCA
|
Claire H Bristow |
SELL
Bona fide gift
|
Indirect | 198 Reduced 0.56% |
-
|
Feb 28
2020 |
TLI
|
Bulldog Investors, LLP
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 586 Added 2.86% |
$5,737
$9.79 p/Share
|
Feb 28
2020 |
IRDM
|
Robert H Niehaus |
SELL
Bona fide gift
|
Direct | 50,000 Reduced 10.39% |
-
|
Feb 28
2020 |
TRN
|
Brandon Boze
Director |
BUY
Open market or private purchase
|
Indirect | 244,344 Added 0.92% |
$4,987,061
$20.41 p/Share
|
Feb 28
2020 |
PASG
|
Orbimed Advisors LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 373,300 Added 50.0% |
$6,719,400
$18.0 p/Share
|
Feb 28
2020 |
SEIC
|
Stephen Meyer
EXECUTIVE VICE PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 7.51% |
$238,600
$23.86 p/Share
|
Feb 28
2020 |
INVE
|
Bleichroeder LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 100 Added 0.0% |
$448
$4.48 p/Share
|
Feb 28
2020 |
IVZ
|
Kevin M Carome
SMD and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 23,608 Reduced 3.98% |
$339,955
$14.4 p/Share
|
Feb 28
2020 |
IVZ
|
Kevin M Carome
SMD and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 72,862 Added 10.93% |
-
|
Feb 28
2020 |
IVZ
|
Martin L Flanagan
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 126,008 Reduced 15.96% |
$1,814,515
$14.4 p/Share
|
Feb 28
2020 |
IVZ
|
Martin L Flanagan
President & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 377,226 Added 32.33% |
-
|
Feb 28
2020 |
IVZ
|
Mark F Giuliano
SMD & Chief Adm Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,561 Reduced 4.52% |
$51,278
$14.4 p/Share
|
Feb 28
2020 |
IVZ
|
Mark F Giuliano
SMD & Chief Adm Officer |
BUY
Grant, award, or other acquisition
|
Direct | 33,159 Added 29.64% |
-
|
Feb 28
2020 |
IVZ
|
Annette Lege
Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,228 Reduced 4.97% |
$60,883
$14.4 p/Share
|
Feb 28
2020 |
IVZ
|
Annette Lege
Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 10,763 Added 11.22% |
-
|
Feb 28
2020 |
IVZ
|
Andrew Tak Shing Lo
Senior Managing Director |
BUY
Exercise of conversion of derivative security
|
Direct | 86,762 Added 13.21% |
-
|
Feb 28
2020 |
IVZ
|
Gregory Mc Greevey
Senior Managing Director |
SELL
Payment of exercise price or tax liability
|
Direct | 31,151 Reduced 5.64% |
$448,574
$14.4 p/Share
|
Feb 28
2020 |
IVZ
|
Gregory Mc Greevey
Senior Managing Director |
BUY
Grant, award, or other acquisition
|
Direct | 121,527 Added 18.04% |
-
|
Feb 28
2020 |
IVZ
|
Colin Meadows
Senior Managing Director |
SELL
Payment of exercise price or tax liability
|
Direct | 34,561 Reduced 9.71% |
$497,678
$14.4 p/Share
|
Feb 28
2020 |
IVZ
|
Colin Meadows
Senior Managing Director |
BUY
Grant, award, or other acquisition
|
Direct | 108,166 Added 23.3% |
-
|
Feb 28
2020 |
IVZ
|
Andrew Schlossberg
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 17,321 Reduced 10.01% |
$249,422
$14.4 p/Share
|
Feb 28
2020 |
IVZ
|
Andrew Schlossberg
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 19,415 Added 10.09% |
-
|
Feb 28
2020 |
IVZ
|
Douglas J Sharp
Senior Managing Director |
SELL
Payment of exercise price or tax liability
|
Direct | 11,372 Reduced 16.2% |
$163,757
$14.4 p/Share
|
Feb 28
2020 |
IVZ
|
Loren M Starr
SMD & CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 30,189 Reduced 4.41% |
$434,722
$14.4 p/Share
|
Feb 28
2020 |
IVZ
|
Loren M Starr
SMD & CFO |
BUY
Grant, award, or other acquisition
|
Direct | 96,261 Added 12.33% |
-
|
Feb 28
2020 |
DMTK
|
Rtw Investments, LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 152,456 Added 5.66% |
$1,600,788
$10.5 p/Share
|
Feb 28
2020 |
PNC
|
Andrew T Feldstein
Director |
BUY
Open market or private purchase
|
Indirect | 16,112 Added 24.6% |
$1,989,671
$123.49 p/Share
|
Feb 28
2020 |
PNC
|
Andrew T Feldstein
Director |
BUY
Open market or private purchase
|
Direct | 8,056 Added 19.69% |
$994,835
$123.49 p/Share
|
Feb 28
2020 |
MYMD
|
Hudson Bay Capital Management LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 638 Reduced 0.26% |
$1,793
$2.81 p/Share
|
Feb 28
2020 |
W
|
Spruce House Partnership LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 250,000 Added 3.03% |
$15,420,000
$61.68 p/Share
|
Feb 28
2020 |
CB
|
Philip V Bancroft
Executive Vice President* |
SELL
Payment of exercise price or tax liability
|
Direct | 445 Reduced 0.17% |
$64,538
$145.03 p/Share
|
Feb 28
2020 |
CB
|
Timothy Alan Boroughs
Executive Vice President* |
SELL
Payment of exercise price or tax liability
|
Direct | 373 Reduced 0.21% |
$54,096
$145.03 p/Share
|
Feb 28
2020 |
CB
|
Evan G Greenberg
Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 2,109 Reduced 0.19% |
$305,868
$145.03 p/Share
|
Feb 28
2020 |
CB
|
John W Keogh
President & COO |
SELL
Payment of exercise price or tax liability
|
Direct | 906 Reduced 0.38% |
$131,397
$145.03 p/Share
|
Feb 28
2020 |